Expert Consensus on New Standards of Care for Detecting, Predicting, and Managing Glycemic Excursions in the Hospital
This continuing medical education activity is supported by an independent educational grant from Dexcom.
This activity is intended for hospitalists, primary care physicians, diabetologists & endocrinologists, nurses, nurse practitioners, and pharmacists.
The goal of this activity is for learners to be better able to use real-time continuous glucose monitoring (rtCGM) in hospitalized patients with diabetes for improved clinical outcomes.
Upon successful completion of this activity, participants should:
- Have increased knowledge regarding the
- Data supporting rtCGM use in the hospital (non-intensive care unit [non-ICU] and ICU settings)
- Have greater competence related to
- Practical use of rtCGM in the hospital (non-ICU setting)
- Demonstrate greater confidence in their ability to
- Use data from rtCGM to decrease dysglycemia in the hospitalized patients with diabetes
CONFLICT OF INTEREST POLICY/DISCLOSURE STATEMENT
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Anne G. Le, PharmD
Senior Medical Education Director, Medscape, LLC
Disclosure: Anne G. Le, PharmD, has no relevant financial relationships.
Compliance Reviewer/Nurse Planner
Leigh Schmidt, MSN, RN, CNE, CHCP
Associate Director, Accreditation and Compliance, Medscape, LLC
Disclosure: Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).
College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 1.0 contact hour(s) (0.100 CEUs) (Universal Activity Number: JA0007105-0000-23-144-H01-P).
This enduring material is approved for 1 year from the date of original release, April 17, 2023 to April, 17, 2024.
This activity is accredited through Medscape. Click the link below to claim credit. You will be prompted to create a Medscape account and complete the post-test. If a satisfactory score on the post-test is achieved, Medscape will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Elias K. Spanakis, MD
Associate Professor of Medicine
University of Maryland School of Medicine
Endocrinology, Diabetes and Nutrition Section
VA Maryland Health Care System
Elias K. Spanakis, MD, has the following relevant financial relationships:
- Research funding from: Dexcom
Matt Baker, PharmD, MS, BCPS
Pharmacy Clinical Supervisor
North Kansas City Hospital
North Kansas City, Missouri
Matt Baker, PharmD, MS, BCPS, has the following relevant financial relationships:
- Consultant or advisor for: Dexcom
- Research funding from: Dexcom
Eileen R. Faulds, PhD, MS, RN, FNP-BC, CDCES
Center for Healthy Aging, Self-Management, and Complex Care
The Ohio State University College of Nursing
The Ohio State University Wexner Medical Center
Eileen R. Faulds, PhD, MS, RN, FNP-BC, CDCES, has the following relevant financial relationships:
- Consultant or advisor for: Dexcom; Hexaware, LLC (former)
- Speaker or member of speakers bureau for: Dexcom
- Research funding from: Dexcom
Athena Philis-Tsimikas, MD
Corporate Vice President
Scripps Whittier Diabetes Institute at Scripps Health
Director of Community Engagement
Scripps Research Translational Institute
La Jolla, California
Athena Philis-Tsimikas, MD, has the following relevant financial relationships:
- Consultant or advisor for: Bayer; Dexcom; Lilly; MiniMed; Novo Nordisk
- Research funding from: Dexcom; Lilly; MiniMed; Novo Nordisk